title: Reply to Barroso-Sousa R et al.
authors.affiliation: Amgen, Inc, Thousand Oaks, CA, USA.
authors.forename: Jacob
authors.initials: J
authors.lastname: Garcia
authors.affiliation: Amgen, Inc, Thousand Oaks, CA, USA.
authors.forename: Larry
authors.initials: L
authors.lastname: Green
authors.affiliation: Amgen, Inc, Thousand Oaks, CA, USA. Electronic address: pmorrow@amgen.com.
authors.forename: Phuong Khanh
authors.initials: PK
authors.lastname: Morrow
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D001943:Breast Neoplasms; D016179:Granulocyte Colony-Stimulating Factor; D006098:Granulocytes; D006801:Humans; D009369:Neoplasms; D017239:Paclitaxel; D012189:Retrospective Studies
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D017239:Paclitaxel
keywords: Dose-dense chemotherapy; Febrile neutropenia; G-CSF